Viewing Study NCT03419234

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2026-02-01 @ 7:11 AM
Study NCT ID: NCT03419234
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-13
First Post: 2018-01-26
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration Levels of Testosterone View
None Castration-Resistant Prostate Carcinoma View
None Metastatic Prostate Carcinoma in the Soft Tissue View
None Prostate Carcinoma Metastatic in the Bone View
None Stage IV Prostate Adenocarcinoma AJCC v7 View
Keywords: